423 results on '"Navarro-Compán, V."'
Search Results
2. OP0085 CLINICAL FEATURES OF PATIENTS WITH SpA, WITH OR WITHOUT IBD: RESULTS FROM THE METEOR COHORT
3. POS0508 WHAT FACTORS ARE ASSOCIATED WITH PAIN INTENSITY IN AXIAL SPONDYLOARTHRITIS? RESULTS FROM THE INTERNATIONAL MAP OF AXIAL SPONDYLOARTHRITIS (IMAS)
4. AB0897 PREDICTIVE MODELS TO FORECAST DIFFICULT-TO-MANAGE AXIAL SPONDYLOARTHRITIS
5. AB0958 HOW ARE PATIENT REPORTED OUTCOME MEASUREMENTS USED IN AXIAL SPONDYLOARTHRITIS? A QUALITATIVE STUDY WITH HEALTH CARE PROFESSIONALS AND PATIENTS
6. POS0194 FACTORS ASSOCIATED WITH RADIOGRAPHIC SPINAL PROGRESSION IN PATIENTS WITH AXIAL SPONDYLOARTHRITIS RECEIVING IL-17A INHIBITOR OR TNF INHIBITOR THERAPY: A POST-HOC ANALYSIS OF THE SURPASS STUDY
7. POS0215 LONG-TERM SAFETY AND EFFICACY OF BIMEKIZUMAB IN PATIENTS WITH ACTIVE ANKYLOSING SPONDYLITIS: 5-YEAR RESULTS FROM A PHASE 2B STUDY AND ITS OPEN-LABEL EXTENSION
8. AB0945 THE IMPACT OF AXIAL SPONDYLOARTHRITIS ON PATIENTS’ SEXUAL LIFE. RESULTS FROM THE INTERNATIONAL MAP OF AXIAL SPONDYLOARTHRITIS (IMAS)
9. POS0799 EFFICACY OF BDMARDS IN EARLY VERSUS ESTABLISHED DISEASE IN AXIAL SPONDYLOARTHRITIS: A META-ANALYSIS OF RANDOMIZED TRIALS
10. POS0507 FACTORS ASSOCIATED WITH POOR MENTAL HEALTH IN PATIENTS WITH AXIAL SPONDYLOARTHRITIS. RESULTS FROM THE INTERNATIONAL MAP OF AXIAL SPONDYLOARTHRITIS (IMAS)
11. Biochemical algorithm to identify individuals with ALPL variants among subjects with persistent hypophosphatasaemia
12. Influence of smoking and obesity on treatment response in patients with axial spondyloarthritis: a systematic literature review
13. Evaluación de la densidad mineral ósea y de los parámetros de 3D-Shaper en la hipofosfatasia congénita del adulto
14. Le bimékizumab permet le maintien des réponses cliniques évaluées par des critères stricts jusqu’à la semaine 52 chez les patients atteints de spondyloarthrite axiale : résultats des études de phase III BE MOBILE 1 et BE MOBILE 2
15. Tolérance et efficacité à long terme du bimékizumab chez les patients atteints de spondylarthrite ankylosante active : résultats à 5 ans d’une étude de phase IIb et de son extension en ouvert
16. Effet du sécukinumab versus adalimumab biosimilaire sur la progression radiographique chez les patients atteints de spondyloarthrite axiale radiographique : analyse en sous-groupes avec sur le statut syndesmophytes et protéine C-réactive à l’inclusion
17. Le bimékizumab réduit les lésions inflammatoires à l’IRM chez les patients atteints de spondyloarthrite axiale : résultats à la semaine 52 des études de phase III BE MOBILE 1 et 2
18. Moins de 10 % de probabilité de progression radiographique à 10 ans chez les patients avec spondyloarthrite axiale (axSpA) récente, et probablement moins de 5 % s’ils reçoivent un anti-TNF alpha : données de la cohorte DESIR
19. Effet du sécukinumab versus adalimumab biosimilaire sur la progression radiographique chez les patients atteints de spondyloarthrite axiale radiographique : étude randomisée de phase 3b
20. Can we identify individuals with an ALPL variant in adults with persistent hypophosphatasaemia?
21. Pain and inflammation as mediators of tofacitinib treatment effect on fatigue in patients with ankylosing spondylitis: a mediation analysis
22. POS0246 BIMEKIZUMAB REDUCED MRI INFLAMMATORY LESIONS IN PATIENTS WITH AXIAL SPONDYLOARTHRITIS: WEEK 52 RESULTS FROM THE BE MOBILE 1 AND BE MOBILE 2 PHASE 3 STUDIES
23. POS0675 LOW RATE OF SWITCHING FROM NR-AXSPA TO R-AXSPA AFTER 10 YEARS OF FOLLOW UP IN EARLY AXIAL SPONDYLOARTHRITIS. DATA FROM DESIR COHORT
24. AB0994 HOW SPONDYLOARTHRITIS PROFILE HAS EVOLVED OVERTIME: RESULTS FROM GESPA COLOMBIAN COHORT
25. POS0676 THE CHALLENGE OF IDENTIFYING DIFFICULT-TO-TREAT AXIAL SPONDYLOARTHRITIS IN CLINICAL PRACTICE: RESULTS FROM LA PAZ-SPA COHORT
26. AB1000 ACHIEVEMENT OF INCREASINGLY STRINGENT CLINICAL RESPONSE CRITERIA AND LOWER LEVELS OF DISEASE ACTIVITY WAS ASSOCIATED WITH GREATER IMPROVEMENTS IN PHYSICAL FUNCTION AND HRQOL IN PATIENTS WITH ACTIVE AXIAL SPONDYLOARTHRITIS: 52-WEEK RESULTS FROM TWO PHASE 3 STUDIES ON BIMEKIZUMAB
27. AB1010 WHICH FACTORS ARE ASSOCIATED WITH CLINICALLY HIGH DISEASE ACTIVITY IN AXIAL SPONDYLOARTHRITIS? RESULTS FROM THE INTERNATIONAL MAP OF AXIAL SPONDYLOARTHRITIS (IMAS)
28. POS1108 EFFICACY OF UPADACITINIB IN PATIENTS WITH NON-RADIOGRAPHIC AXIAL SPONDYLOARTHRITIS IN EARLY VERSUS ESTABLISHED DISEASE
29. AB1076 SPECTRUM OF AXIAL SPONDYLOARTHRITIS IN COLOMBIAN’S PATIENTS: NON-RADIOGRAPHIC VS RADIOGRAPHIC AXIAL SPA. RESULTS FROM GESPA COLOMBIAN COHORT
30. AB1023 THE DIFFERENTIAL CHARACTERISTIC OF SPONDYLOARTHRITIS PATIENTS WHO CANNOT BE CLASSIFIED ACCORDING TO ASAS: RESULTS FROM THE GESPA COLOMBIAN COHORT
31. OP0187 REGIONAL DIFFERENCES IN CLINICAL PHENOTYPE OF AXIAL SPONDYLOARTHRITIS. RESULTS FROM THE INTERNATIONAL MAP OF AXIAL SPONDYLOARTHRITIS (IMAS)
32. AB0979 SELF-REPORTED AND PHYSICIAN´S ASSESSMENT OF INFLAMMATORY BACK PAIN ACCORDING TO ASAS CRITERIA: IS IT THE SAME? RESULTS FROM THE SHERPAS STUDY
33. POS1104 BIMEKIZUMAB MAINTAINED STRINGENT CLINICAL RESPONSES THROUGH WEEK 52 IN PATIENTS WITH AXIAL SPONDYLOARTHRITIS: RESULTS FROM THE PHASE 3 STUDIES BE MOBILE 1 AND BE MOBILE 2
34. POS0683 AN EXPLORATORY ANALYSIS OF THE POTENTIAL DISCONNECT BETWEEN OBJECTIVE INFLAMMATORY RESPONSE AND CLINICAL RESPONSE FOLLOWING CERTOLIZUMAB PEGOL TREATMENT IN PATIENTS WITH ACTIVE AXIAL SPONDYLOARTHRITIS
35. AB1592 WORK-RELATED IMPACT IN YOUNG PATIENTS WITH CHRONIC BACK PAIN AWAITING A MAGNETIC RESONANCE IMAGING
36. POS0689 DIAGNOSTIC DELAY IN PATIENTS INCLUDED IN THE INTERNATIONAL MAP OF AXIAL SPONDYLOARTHRTIS: ASSOCIATIONS WITH GEOGRAPHIC, SOCIO-DEMOGRAPHIC AND DISEASE-RELATED FACTORS
37. POS1106 ACHIEVEMENT OF LOW DISEASE ACTIVITY OVER 52 WEEKS IN PATIENTS WITH ACTIVE AXIAL SPONDYLOARTHRITIS ON BIMEKIZUMAB TREATMENT: RESULTS FROM THE PHASE 3 STUDIES BE MOBILE 1 AND BE MOBILE 2
38. AB0987 FEMALES WITH AXIAL SPONDYLOARTHRITIS REPORT HIGHER BURDEN OF DISEASE AND WORSE PATIENT-REPORTED OUTCOMES. RESULTS FROM THE INTERNATIONAL MAP OF AXIAL SPONDYLOARTHRITIS (IMAS)
39. OP0059 EFFECT OF SECUKINUMAB VERSUS ADALIMUMAB BIOSIMILAR ON RADIOGRAPHIC PROGRESSION IN PATIENTS WITH RADIOGRAPHIC AXIAL SPONDYLOARTHRITIS: A RANDOMISED PHASE IIIB STUDY
40. OP0008 EULAR RECOMMENDATIONS FOR THE USE OF IMAGING IN THE DIAGNOSIS AND MANAGEMENT OF CRYSTAL-INDUCED ARTHROPATHIES IN CLINICAL PRACTICE
41. POS0298 THE INTERNATIONAL MAP OF AXIAL SPONDYLOARTHRITIS (IMAS). RESULTS FROM THE PERSPECTIVE OF 5,557 PATIENTS FROM 27 COUNTRIES AROUND THE WORLD
42. OP0055 ASAS CONSENSUS DEFINITION OF EARLY AXIAL SPONDYLOARTHRITIS
43. POS0083 A SYSTEMATIC LITERATURE REVIEW INFORMING THE EULAR RECOMMENDATIONS FOR THE USE OF IMAGING IN CRYSTAL-INDUCED ARTHRITIS IN CLINICAL PRACTICE
44. OP0061 DEVELOPMENT OF EXTRA-MUSCULOSKELETAL MANIFESTATIONS IN UPADACITINIB-TREATED PATIENTS WITH PSORIATIC ARTHRITIS, ANKYLOSING SPONDYLITIS, OR NON-RADIOGRAPHIC AXIAL SPONDYLOARTHRITIS
45. AB1069 GENDER DIFFERENCES IN PRESENTATION, CLASSIFICATION, AND DISEASE ACTIVITY OF SPONDYLOARTHRITIS: RESULTS FROM GESPA COLOMBIAN COHORT
46. AB1314 EFFICACY AND SAFETY OF ANTI-SARS-CoV-2 VACCINATION IN PEOPLE WITH RMDs: RESULTS FROM A SYSTEMATIC LITERATURE REVIEW
47. POS0563 USE OF A DIGITAL SOLUTION TO MONITOR CHRONIC INFLAMMATORY RHEUMATIC MUSCULOSKELETAL DISEASES: FINAL RESULTS OF THE DIGIREUMA STUDY
48. AB1400 SPINE AND SACROILIAC JOINTS FINDINGS IN YOUNG MALES AND FEMALES WITH CHRONIC BACK PAIN UNDERGOING MAGNETIC RESONANCE IMAGING IN CLINICAL PRACTICE: RESULTS FROM THE SHERPAS STUDY
49. POS1116 TIME TO IMPROVEMENT OF PAIN, MORNING STIFFNESS AND DISEASE ACTIVITY IN PATIENTS WITH ANKYLOSING SPONDYLITIS TREATED WITH TOFACITINIB
50. PCR196 Association of Clinical Response Criteria and Disease Activity Levels With Physical Function and HRQoL in Patients With Active Axial Spondyloarthritis: 16-Week Results From Two Phase 3 Randomised, Placebo-Controlled Studies
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.